Literature DB >> 20088942

The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.

K Rychli1, C Kaun, P J Hohensinner, G Rega, S Pfaffenberger, E Vyskocil, J M Breuss, A Furnkranz, P Uhrin, J Zaujec, A Niessner, G Maurer, K Huber, J Wojta.   

Abstract

OBJECTIVES: Members of the glycoprotein 130 (gp130) receptor-gp130 ligand family play a role in angiogenesis in different tissues. We tested the effect of this cytokine family on the angiopoietin (Ang)-Tie system, which is involved in blood vessel maturation, stabilization, and regression.
RESULTS: Oncostatin M (OSM) increased Ang2 expression in human umbilical vein endothelial cells via Janus kinase/signal transducer and activator of transcription (JAK/STAT) and mitogen-activated protein (MAP) kinase activation. Furthermore, OSM induced Ang2 expression in macrovascular endothelial cells isolated from the human aorta and in microvascular endothelial cells isolated from human heart. Our in vivo experiments revealed that mRNA expression of Ang2 in hearts of mice injected with OSM increased significantly, and levels of OSM mRNA significantly correlated with mRNA levels of Ang2 in human hearts. In addition, OSM increased the expression of its own receptors, gp130 and OSM receptor, in endothelial cells in vitro and in mice in vivo, and levels of OSM mRNA significantly correlated with mRNA levels of gp130 and OSM receptor in human hearts.
CONCLUSION: Our data, showing the effects of OSM on the Ang-Tie system in endothelial cells, in hearts of mice, and in human heart tissue, provide yet another link between inflammation and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20088942      PMCID: PMC2857505          DOI: 10.1111/j.1538-7836.2010.03741.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  39 in total

Review 1.  Oncostatin M: signal transduction and biological activity.

Authors:  M J Gómez-Lechón
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 2.  Phenotypic heterogeneity of the endothelium: II. Representative vascular beds.

Authors:  William C Aird
Journal:  Circ Res       Date:  2007-02-02       Impact factor: 17.367

3.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies.

Authors:  Ulrike Fiedler; Marion Scharpfenecker; Stefanie Koidl; Anja Hegen; Verena Grunow; Jarno M Schmidt; Wilhelm Kriz; Gavin Thurston; Hellmut G Augustin
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

4.  Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro.

Authors:  J Wojta; H Zoellner; M Gallicchio; J A Hamilton; K McGrath
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

5.  Fibrinolytic system of cultured rabbit aortic endothelial cells.

Authors:  D B al-Azhary; J Wojta; B R Binder
Journal:  Thromb Res       Date:  1994-09-01       Impact factor: 3.944

6.  Interleukin 6 induces the expression of vascular endothelial growth factor.

Authors:  T Cohen; D Nahari; L W Cerem; G Neufeld; B Z Levi
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

7.  Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.

Authors:  Kaeng W Lee; Gregory Y H Lip; Andrew D Blann
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

8.  Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.

Authors:  Shih-Pei Huang; Ming-Shiang Wu; Chia-Tung Shun; Hsiu-Po Wang; Ming-Tsan Lin; Min-Liang Kuo; Jaw-Town Lin
Journal:  J Biomed Sci       Date:  2004 Jul-Aug       Impact factor: 8.410

9.  Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.

Authors:  Reena Sandhu; Krystyna Teichert-Kuliszewska; Sukriti Nag; Gerald Proteau; Malcolm J Robb; Andrew I M Campbell; Michael A Kuliszewski; Michael J B Kutryk; Duncan J Stewart
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.

Authors:  J Wojta; H Zoellner; M Gallicchio; E L Filonzi; J A Hamilton; K McGrath
Journal:  Lymphokine Cytokine Res       Date:  1994-04
View more
  14 in total

1.  Endothelium-derived GM-CSF influences expression of oncostatin M.

Authors:  Wafa M Elbjeirami; Elizabeth M Donnachie; Alan R Burns; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

2.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

3.  Pulmonary instillation of MWCNT increases lung permeability, decreases gp130 expression in the lungs, and initiates cardiovascular IL-6 transsignaling.

Authors:  Leslie C Thompson; Nathan A Holland; Ryan J Snyder; Bin Luo; Daniel P Becak; Jillian T Odom; Benjamin S Harrison; Jared M Brown; Kymberly M Gowdy; Christopher J Wingard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

Review 4.  Inflammation and cardiac outcome.

Authors:  Philipp J Hohensinner; Alexander Niessner; Kurt Huber; Cornelia M Weyand; Johann Wojta
Journal:  Curr Opin Infect Dis       Date:  2011-06       Impact factor: 4.915

5.  Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice.

Authors:  Michael R Preusch; Nicholas Ieronimakis; Errol S Wijelath; Sara Cabbage; Jerry Ricks; Florian Bea; Morayma Reyes; Joanne van Ryn; Michael E Rosenfeld
Journal:  Drug Des Devel Ther       Date:  2015-09-10       Impact factor: 4.162

6.  OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction.

Authors:  Xiaotian Zhang; Di Zhu; Liping Wei; Zhijing Zhao; Xin Qi; Zongjin Li; Dongdong Sun
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

Review 7.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08

8.  Novel classification for global gene signature model for predicting severity of systemic sclerosis.

Authors:  Zariel I Johnson; Jacqueline D Jones; Angana Mukherjee; Dianxu Ren; Carol Feghali-Bostwick; Yvette P Conley; Cecelia C Yates
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

9.  Changes in Neuronal Signaling and Cell Stress Response Pathways are Associated with a Multigenic Response of Drosophila melanogaster to DDT Selection.

Authors:  Keon Mook Seong; Brad S Coates; Weilin Sun; John M Clark; Barry R Pittendrigh
Journal:  Genome Biol Evol       Date:  2017-12-01       Impact factor: 3.416

10.  Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients.

Authors:  Sagus Sampath; Haejung Won; Erminia Massarelli; Min Li; Paul Frankel; Nayana Vora; Lalit Vora; Ellie Maghami; Marcin Kortylewski
Journal:  Oncotarget       Date:  2018-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.